Timothy P. Walbert - 30 Jun 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Chairman, President and CEO, Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
HZNP
Transactions as of
30 Jun 2021
Transactions value $
-$2,346,380
Form type
4
Filing time
02 Jul 2021, 17:01:11 UTC
Previous filing
16 Jun 2021
Next filing
30 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Sale -$2.21M -23.6K -2.69% $93.80 852K 30 Jun 2021 Direct F1, F2
transaction HZNP Ordinary Shares Sale -$133K -1.41K -0.17% $94.78 851K 30 Jun 2021 Direct F1, F3
holding HZNP Ordinary Shares 21K 30 Jun 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.42 to $94.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.51 to $94.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.